The Rilpivirine Cerebrospinal-fluid (CSF) Study

Summary

This is a phase I pharmacokinetic study of HIV positive patients stable on antiretroviral therapy who will switch treatment when enrolled from nevirapine to rilpivirine. On day 60 of the study the participants will attend clinic where they will have blood collected followed by a lumbar puncture where cerebrospinal fluid will be collected to measure drug concentration. The participants will then restart their original regime with nevirapine.

Timeline

Start

2012-03

Primary completion

2012-11

Completion

2013-02

Drugs

Indications